C83.10
Mantle cell lymphoma, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Mantle cell lymphoma (MCL) is a type of non-Hodgkin lymphoma, which is a cancer that begins in the lymphatic system. Specifically, it originates from B-cells located in the mantle zone of lymph nodes. The ICD-10 code C83.10 refers to cases of MCL where the specific site of the lymphoma has not been identified. MCL is considered an aggressive form of lymphoma, but with advances in treatment options, many patients can manage the disease effectively. It typically affects adults, especially those over the age of 60, and is slightly more common in men than women.
Causes & Symptoms
Clinical Causes: Age-related changes in the immune system Genetic mutations, such as the overexpression of the CCND1 gene due to the t(11;14)(q13;q32) chromosomal translocation Exposure to certain environmental toxins or chemicals A personal or family history of other lymphoid cancers Infections that affect the immune system, although these are less common
Key Symptoms: Swelling or painless enlargement of lymph nodes in the neck, armpits, or groin Persistent fatigue or weakness Unexplained weight loss Fever or night sweats Frequent infections due to immune system suppression Abdominal pain or swelling, if the spleen or liver is affected Loss of appetite Persistent cough or difficulty breathing if the chest lymph nodes are involved
Diagnostic & Treatment
Diagnosis Path: Physical examinations to check for swollen lymph nodes Blood tests to evaluate overall health and detect abnormal cells Imaging studies like PET scans, CT scans, or MRI to determine the extent of the disease Lymph node biopsy to examine tissue samples for cancer cells Immunophenotyping and genetic testing to identify characteristic markers and genetic translocations, such as t(11;14)
Treatment Protocols: Chemotherapy to kill cancer cells Targeted therapies, such as ibrutinib or acalabrutinib, which focus on specific molecules involved in cancer growth Immunotherapy, including monoclonal antibodies like rituximab Stem cell transplantation, considered for eligible patients to achieve long-term remission Radiation therapy in localized cases Clinical trials offering access to promising new treatments
Clinical Advice & FAQs
Billing Guidance
Is C83.10 a billable ICD-10 code?
Yes, C83.10 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C83.10?
Clinical documentation must specify the nature of Mantle cell lymphoma, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference